You are here

2013 Publications

McLinden, R., LaBranche, C., Chenine, A., Polonis, V., Eller, M., Wieczorek, L., Ochsenbauer, C., Kappes, J., Perfetto, S., Montefiori, D., Michael, N., and Kim, J. Detection of HIV-1 Neutralizing Antibodies in a Human CD4+/CXCR4+/CCR5+ T-Lymphoblastoid Cell Assay System. PLoS ONE. 2013 Nov 28;8(11).

Wieczorek, L., Brown, B., Macedo, C.D., Schmierer, M.W., Ngauy, V., Rosa Borges, A., Michael, N., Marovich, M., Montefiori, D., Polonis, V. Mitigation of variation observed in a peripheral blood mononuclear cell (PBMC) based HIV-1 neutralization assay by donor cell pooling. J. Virol. 2013 Dec;447(1-2):240-8. Epub 2013 Oct 5.

Barouch, D.H., Stephenson, K.E., Borducci, E.N., Smith, K., Stanley, K., McNally, A.G., Liu, J., Abbink, P., Maxfield, L.F., Seaman, M.S., Dugast, A.S., Alter, G., Ferguson, M., Li, W., Earl, P.L., Moss, B., Giorgi, E.E., Szinger, J.J., Eller, L.A., Billings, E., Rao, M., Tovanabutra, S., Sanders-Buell, E., Weijtens, M., Pau, M.G., Schuitemaker, H., Robb, M.L., Kim, J.H., Korber, B.T., Michael, N.L. Protective Efficacy of a Global HIV-1 Mosaic Vaccine Against Acquisition of Heterologous Simian-Human Immunodeficiency Virus Challenges in Rhesus Monkeys. Cell. 2013 October 24;155:1-9.

Gottardo, R., Bailer, R.T., Korber, B.T., Gnanakaran, S., Phillips, J., Shen, X., Tomaras, G.D., Imholte, G., Eckler, L., Wenschuh, H., Zerweck, J., Greene, K., Gao, H., Berman, P.W., Francis, D., Sinangil, F., Lee, C., Nitayaphan, S., Rerks-Ngarm, S., Kaewkungwal, J., Pitisuttithum, P., Tartaglia, J., Robb, M.L., Michael, N.L., Kim, J.H., Haynes, B.F., Mascola, J.R., Self, S., Gilbert, P., Montefiori, D.C. Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 as Correlates of Infection Risk in the RV144 Vaccine Efficacy Trial. PLoS ONE. 2013 Sep 26;8(9).

Kijak, G.H., Pham, P., Sanders-Buell, E., Harbolick, E., Eller, L.A., Robb, M., Michael, N., Kim, J.H., Tovanabutra, S. Nautilus: A Bioinformatics Package for the Analysis of HIV-1 Targeted Deep Sequencing Data. AIDS Res Hum Retroviruses. 2013 Oct;29(10):1361-4. Epub 2013 Aug 2.

Koehler, R.N., Alter, G., Tovanabutra, S., Saathoff, E., Arroyo, M., Walsh, A.M., Sanders-Buell, E., Maboko, L., Hoelscher, M., Robb, M.L., Michael, N.L., McCutchan, F.E., Kim, J.H., and Kijak, G.H. Natural killer cell-mediated innate sieve effect on HIV-1: the impact of KIR/HLA polymorphism on HIV-1 subtype-specific acquisition in East Africa. J Infect Dis. 2013 Oct;208(8):1250-4. Epub 2013 Aug 13.

Heipertz Jr, R.A., Sanders-Buell, E., Kijak, G., Howell, S., Lazzaro, M., Jagodzinski, L.L., Eggleston, J., Peel, S., Malia, J., Armstrong, A., Michael, N.L., Kim, J.H., O'Connell, R.J., Scott, P.T., Brett-Major, D.M., and Tovanabutra, S. Molecular Epidemiology of Early and Acute HIV-1 Infections in the United States Navy and Marine Corps, 2005-2010. AIDS Res Hum Retroviruses. 2013 Oct;29(10):1310-20.

Rerks-Ngarm, S., Paris, R.M., Chunsutthiwat, S., Premsri, N., Namwat, C., Bowonwatanuwong, C., Li, S.S., Kaewkungkal, J., Trichavaroj, R., Churikanont, N., de Souza, M.S., Andrews, C., Francis, D., Adams, E., Flores, J., Gurunathan, S., Tartaglia, J., O'Connell, R.J., Eamsila, C., Nitayaphan, S., Ngauy, V., Thongcharoen, P., Kunasol, P., Michael, N.L., Robb, M.L., Gilbert, P.B., Kim, J.H. Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a Phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E. J Infect Dis. 2013; 07(8):1195-205. Epub 2012 Sept 12.

Chalermchai, T., Valcour, V., Sithinamsuwan, P., Pinyakorn, S., Clifford, D., Paul, R.H., Tipsuk, S., Fletcher, J.L., Degruttola, V., Ratto-Kim, S., Hutchings, N., Shikuma, C., Ananworanich, J. Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND. J Neurovirol. 2013; 19(2):137-43.

Boonnak, K., Slike, B.M., Donofrio, G.C., Marovich, M.A. Human FcgammaRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection. J Immunol. 2013; 190(11):5659-65.

Graham BS, Enama ME, Nason MC, Gordon IJ, Peel SA, Ledgerwood JE, Plummer SA, Mascola JR, Bailer RT, Roederer M, Koup RA, Nabel GJ; VRC 008 Study Team. DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial. PLoS One. 2013;8(4):e59340. Epub 2013 Apr 8.

Matyas GR, Mayorov AV, Rice KC, Jacobson AE, Cheng K, Iyer MR, Li F, Beck Z, Janda KD, Alving CR. Liposomes containing monophosphoryl lipid A: A potent adjuvant system for inducing antibodies to heroin hapten analogs. Vaccine. 2013 Jun 10;31(26):2804-10. Epub 2013 Apr 23.

Ananworanich J, Fletcher JL, Pinyakorn S, van Griensven F, Vandergeeten C, Schuetz A, Pankam T, Trichavaroj R, Akapirat S, Chomchey N, Phanuphak P, Chomont N, Michael NL, Kim JH, de Souza M; RV254/SEARCH 010 Study Group. A novel acute HIV infection staging system based on 4th generation immunoassay. Retrovirology. 2013 May 29;10:56.

Tomaras GD, Ferrari G, Shen X, Alam SM, Liao HX, Pollara J, Bonsignori M, Moody MA, Fong Y, Chen X, Poling B, Nicholson CO, Zhang R, Lu X, Parks R, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Gilbert PB, Kim JH, Michael NL, Montefiori DC, Haynes BF. Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG. Proc Natl Acad Sci U S A. 2013 May 28;110(22):9019-9024. Epub 2013 May 9.
 

Zango A, Dubé K, Kelbert S, Meque I, Cumbe F, et al. Determinants of Prevalent HIV Infection and Late HIV Diagnosis among Young Women with Two or More Sexual Partners in Beira, Mozambique. PLoS ONE. 2013 8(5): e63427.

Liu, P, Yates, NL, Shen, X, Bonsignori, M, Moody, MA, Liao, H, Fong, Y, Alam, SM, Overman, RG, Denny, T, Ferrari, G, Ochsenbauer, C, Kappes, JC, Polonis, V, Pitisuttihum, P, Kaewkungwal, J, Nitayaphan, S, Rerks-Ngarm, S, Montefiori, DC, Gilbert, P, Michael, NL, Kim, JH, Haynes, BF, Tomaras, GD. Infectious Virion Capture by HIV-1 gp120 Specific IgG from RV144 Vaccinees. J. Virol. 2013 July;87(14): 7828-36. Epub 2013 May 8.

Kijak GH, Tovanabutra S, Rerks-Ngarm S, Nitayaphan S, Eamsila C, Kunasol P, Khamboonruang C, Thongcharoen P, Namwat C, Premsri N, Benenson M, Morgan P, Bose M, Sanders-Buell E, Paris R, Robb ML, Birx DL, De Souza MS, McCutchan FE, Michael NL, Kim JH. Molecular Evolution of the HIV-1 Thai Epidemic between the Time of RV144 Immunogen Selection to the Execution of the Vaccine Efficacy Trial. J Virol. 2013 Jul;87(13):7265-81. Epub 2013 Apr 10.

Apps, R., Qi, Y., Carlson, J.M., Chen, H., Gao, X., Thomas, R., Yuki, Y., Del Prete, G.Q., Goulder, P., Brumme, Z.L., Brumme, C.J., John, M., Mallal, S., Nelson, G., Bosch, R., Heckerman, D., Stein, J.L., Soderberg, K.A., Moody, M.A., Denny, T.N., Zeng, X., Fang, J., Moffett, A., Lifson, J.D., Goedert, J.J., Buchbinder, S., Kirk, G.D., Fellay, J., McLaren, P., Deeks, S.G., Pereyra, F., Walker, B., Michael, N.L., Weintrob, A., Wolinsky, S., Liao, W., Carrington, M. Opposing effects of HLA-C expression level in viral versus inflammatory disease. Science. 2013 April 5;340:87-91.

Larson BA, Bii M, Henly-Thomas S, McCoy K, Sawe F, Shaffer D, Rosen S. ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics. J Int AIDS Soc. 2013 Jan 2;16:18026.

Liao, H., Bonsignori, M., Munir Alam, S., McLellan, J.S., Tomaras, G.D., Moody, M.A., Kozink, D.M., Hwang, K., Chen, X., Tsao, C., Liu, P., Lu, X., Parks, R.J., Montefiori, D., Ferrari, G., Pollara, J., Rao, M., Peachman, K., Santra, S., Letvin, N.L., Karasavvas, N., Yang, Z., Dai, K., Pancera, M., Gorman, J., Wiehe, K., Nicely, N.I., Rerks-Ngarm, S., Nitayaphan, S., Kaewkungwal, J., Pittisuttihum, P., Tartaglia, J., Sinangil, F., Kim, J.H., Michael, N.L., Kepler, T.B., Kwong, P.D., Mascola, J.R., Nabel, G., Pinter, A., Zolla-Pazner, S., Haynes, B. Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2. Immunity. 2013 Jan 24;38(1):176-86.

Flach, B., Naluyima, P., Blom, K.G., Gonzalez, V.D., Eller, L.A., Laeyendecker, O., Quinn, T.C., Serwadda, D., Sewankambo, N.K., Wawer, M.J., Gray, R.H., Michael, N.L., Wabwire-Manger, F., Robb, M.L., Eller, M.A., Sandberg, J.K.  2012. Differential loss of invariant NKT cells and FoxP3+ regulatory T cells in HIV-1 subtype A and subtype D infections. J. AIDS. 2013 Jul 1; 63(3): 289-93. Epub 2013 Feb 11.

Sawe, F., Lockman, S. Editorial Commentary: To B or Not to B? That Is the Question, for Global Mother-to-Child HIV-1 Transmission Prevention Programs. Clin Infect Dis. 2013; 56(3):447-9.

Streeck, H., D'Souza, M.P., Littman, D.R., Crotty, S. Harnessing CD4+ T cell responses in HIV vaccine development. Nat Med. 2013 Feb;19(2):143-9. Epub 2013 Feb 6.

Hakre S, Manak MM, Murray CK, Davis KW, Bose M, Harding AJ, Maas PR, Jagodzinski LL, Kim JH, Michael NL, Rentas FJ, Peel SA, Scott PT, Tovanabutra S. Transfusion-transmitted human T-lymphotropic virus Type I infection in a United States military emergency whole blood transfusion recipient in Afghanistan, 2010. Transfusion. 2013 Jan 30. [Epub ahead of print]

Elizaga ML, Vasan S, Marovich MA, Sato AH, Lawrence DN, Chaitman BR, Frey SE, Keefer MC; MVA Cardiac Safety Working Group. Prospective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia Ankara vaccines: a systematic review. PLoS One. 2013;8(1):e54407. Epub 2013 Jan 17.

Hakre S, Arteaga G, Núñez AE, Bautista CT, Bolen A, Villarroel M, Peel SA, Paz-Bailey G, Scott PT, Pascale JM; Panama HIV EPI Group. Prevalence of HIV and other sexually transmitted infections and factors associated with syphilis among female sex workers in Panama. Sex Transm Infect. 2013 Mar;89(2):156-64. Epub 2012 Sep 21.

O'Connell RJ, Gates RG, Bautista CT, Imbach M, Eggleston JC, Beardsley SG, Manak MM, Gonzales R, Rentas FJ, Macdonald VW, Cardo LJ, Reiber DT, Stramer SL, Michael NL, Peel SA. Laboratory evaluation of rapid test kits to detect hepatitis C antibody for use in predonation screening in emergency settings. Transfusion. 2013 Mar;53(3):505-17. Epub 2012 Jul 23.

O'Connell, R.J., Gates, R.G., Bautista, C.T., Imbach, M., Eggleston, J.C., Beardsley, S.G., Manak, M.M., Gonzales, R., Rentas, F.J., Macdonald, V.W., Cardo, L.J., Reiber, D.T., Stramer, S.L., Michael, N.L., Peel, S.A. Laboratory evaluation of rapid test kits to detect hepatitis C antibody for use in predonation screening in emergency settings. Transfusion. 2013; 53(3):505-17.

Lesho, E., Ake, J., Huang, X.Z., Cash, D.M., Nikolich, M., Barber, M., Robens, K., Garnett, E., Lindler, L., Scott, P. Amount of usage and involvement in explosions not associated with increased contamination of prehospital vehicles with multi-drug-resistant organisms. Prehosp Disaster Med. 2013; 28(2):107-9. Epub 2012 Dec 21.

Mansoor GF, Rahmani AM, Kakar MA, Hashimy P, Abrahimi P, Scott PT, Peel SA, Rentas FJ, Todd CS. A national mapping assessment of blood collection and transfusion service facilities in Afghanistan. Transfusion. 2013 Jan;53(1):69-75. Epub 2012 May 3.

Zolla-Pazner S, deCamp AC, Cardozo T, Karasavvas N, Gottardo R, Williams C, Morris DE, Tomaras G, Rao M, Billings E, Berman P, Shen X, Andrews C, O'Connell RJ, Ngauy V, Nitayaphan S, de Souza M, Korber B, Koup R, Bailer RT, Mascola JR, Pinter A, Montefiori D, Haynes BF, Robb ML, Rerks-Ngarm S, Michael NL, Gilbert PB, Kim JH. Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial. PLoS One. 2013;8(1):e53629. Epub 2013 Jan 17.

Hu H, Nau M, Ehrenberg P, Chenine AL, Macedo C, Zhou Y, Daye ZJ, Wei Z, Vahey M, Michael NL, Kim JH, Marovich M, Ratto-Kim S. Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection. Blood. 2013 Feb 14;121(7):1136-44. Epub 2012 Dec 20.

Pegu P, Vaccari M, Gordon S, Keele BF, Doster M, Guan Y, Ferrari G, Pal R, Ferrari MG, Whitney S, Hudacik L, Billings E, Rao M, Montefiori D, Tomaras G, Alam SM, Fenizia C, Lifson JD, Stablein D, Tartaglia J, Michael N, Kim J, Venzon D, Franchini G. Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial. J Virol. 2013 Feb;87(3):1708-19. Epub 2012 Nov 21.

Alam SM, Liao HX, Tomaras GD, Bonsignori M, Tsao CY, Hwang KK, Chen H, Lloyd KE, Bowman C, Sutherland L, Jeffries TL Jr, Kozink DM, Stewart S, Anasti K, Jaeger FH, Parks R, Yates NL, Overman RG, Sinangil F, Berman PW, Pitisuttithum P, Kaewkungwal J, Nitayaphan S, Karasavva N, Rerks-Ngarm S, Kim JH, Michael NL, Zolla-Pazner S, Santra S, Letvin NL, Harrison SC, Haynes BF. Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion. J Virol. 2013 Feb;87(3):1554-68. Epub 2012 Nov 21.

Michael NL. Cooling off the host immune response to acute simian immunodeficiency virus infection--is less more? J Infect Dis. 2013 Mar;207(6):875-6. Epub 2012 Oct 24.

Excler, J.L., Tomaras, G.D., Russell, N.D. Novel directions in HIV-1 vaccines revealed from clinical trials. Curr Opin HIV AIDS. 2013 Sep;8(5):421-31.

Mansoor, G.F., Rahmani, A.M., Kakar, M.A., Hashimy, P., Abrahimi, P., Scott, P.T., Peel, S.A., Rentas, F.J., Todd, C.S. Blood supply safety in Afghanistan: a national assessment of high-volume facilities. Transfusion. 2013 Sep; 53(9):2061-8. Epub 2012 May 3.

Beck, Z., Jagodzinski, L.L., Eller, M.A., Thelian, D., Matyas, G.R., Kunz, A.N., Alving, C.R. Platelets and erythrocyte-bound platelets bind infectious HIV-1 in plasma of chronically infected patients. PLoS One. 2013 8(11):e81002.

Chenine, A.L., Wieczorek, L., Sanders-Buell, E., Wesberry, M., Towle, T., Pillis, D.M., Molnar, S., McLinden, R., Edmonds, T., Hirsch, I., O'Connell, R., McCutchan, F.E., Montefiori, D.C., Ochsenbauer, C., Kappes, J.C., Kim, J.H., Polonis, V.R., Tovanabutra, S. Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone. PLoS One. 2013 8(11):e76104.

Crawford, K.W., Li, X., Xu, X., Abraham, A.G., Dobs, A.S., Margolick, J.B., Palella, F.J., Kingsley, L.A., Witt, M.D., Brown, T.T. Lipodystrophy and inflammation predict later grip strength in HIV-infected men: the MACS body composition substudy. AIDS Res Hum Retroviruses. 2013 Aug; 29(8):1138-45.

Edlefsen, P.T., Gilbert, P.B., Rolland, M. Sieve analysis in HIV-1 vaccine efficacy trials. Curr Opin HIV AIDS. 2013 Sep; 8(5):431-5.

Gao, G., Wieczorek, L., Peachman, K.K., Polonis, V.R., Alving, C.R., Rao, M., Rao, V.B. Designing a soluble near full-length HIV-1 gp41 trimer. Journal of Biological Chemistry. 2013 Jan 4; 288(1):234-46.
    
Gray, G.E., Michael, N.L. Cautious optimism for HIV vaccine science. Curr Opin HIV AIDS. 2013 Sep; 8(5):367-8.

Janosi, L., Compton, J.R., Legler, P.M., Steele, K.E., Davis, J.M., Matyas, G.R., Millard, C.B. Disruption of the putative vascular leak peptide sequence in the stabilized ricin vaccine candidate RTA1-33/44-198. Toxins. 2013 5(2):224-48.

Kijak, G.H., Kim, J.H. Timing, Adherence, Resistance, and ... Persistence? New Insight Into the Mechanisms of Failure of HIV Type 1 Postexposure Prophylaxis. Journal of  Infectious Diseases. 2013 Nov; 208(10):1542-4.

Rao, M., Peachman, K.K., Kim, J., Gao, G., Alving, C.R., Michael, N.L., Rao, V.B. HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development. Curr HIV Res. 2013 Jul; 11(5):427-38.

Sanders-Buell, E., Rutvisuttinunt, W., Todd, C.S., Nasir, A., Bradfield, A., Lei, E., Poltavee, K., Savadsuk, H., Kim, J.H., Scott, P.T., de Souza, M., Tovanabutra, S. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan. J Med Virol. 2013 Jul; 85(7):1170-9.

Scott, P.T., Hakre, S., Myles, O., Sanders-Buell, E.E., Kijak, G.H., McCutchan, F.E., O'Connell, R.J., Peel, S.A., Eggleston, J.C., Sateren, W.B., Robb-McGrath, M., Mott, R.L., Tobler, S.K., Nolan, E., Petruccelli, B.P., Michael, N.L., Cersovsky, S.B. Short communication: Investigation of incident HIV infections among U.S. army soldiers deployed to Afghanistan and Iraq, 2001-2007. AIDS Res Hum Retroviruses. 2013 Oct; 28(10):1308-12. 

Tieu, H.V., Rolland, M., Hammer, S.M., Sobieszczyk, M.E. Translational research insights from completed HIV vaccine efficacy trials. Journal of Acquired Immune Deficiency Syndromes. 2013 Jul; 63(Suppl 2):S150-4.

Vaidya, S.A., Streeck, H., Beckwith, N., Ghebremichael, M., Pereyra, F., Kwon, D.S., Addo, M.M., Rychert, J., Routy, J.P., Jessen, H., Kelleher, A.D., Hecht, F., Sekaly, R.P., Carrington, M., Walker, B.D., Allen, T.M., Rosenberg, E.S., Altfeld, M. Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection. Retrovirology. 2013 10(1) 139.

Valcour, V.G., Ananworanich, J., Agsalda, M., Sailasuta, N., Chalermchai, T., Schuetz, A., Shikuma, C., Liang, C.Y., Jirajariyavej, S., Sithinamsuwan, P., Tipsuk, S., Clifford, D.B., Paul, R., Fletcher, J.L., Marovich, M.A., Slike, B.M., Degruttola, V., Shiramizu, B. HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naive Patients. PLoS One. 2013 8(7):e70164.

O'Connell, R., Excler, J.L. HIV Vaccine efficacy and immune correlates of risk. Curr HIV Res. 2013 Sep;11(6):450-63.

Pitisuttithum, P., Rerks-Ngarm, S., O'Connel, R.J., Kim, J.H., Excler, J.-L. An HIV vaccine for South-East Asia--Opportunities and challenges. Vacines. 2013, 1(3), 348-366.

Pitisuttithum, P., Excler, J-L., Kim, J.H. Beyond RV144 Efficacy Results: An Update. Procedia in Vaccinol. 7 (2013), p. 49-56.